Residential sales in Hong Kong continue to improve, and mainland China sales are on track, embattled company says.
The Hong Kong stock market has finished higher in six straight sessions, rallying more than 1,230 points or 6 percent in that span.
Asian equities were higher, except for Hong Kong and Mainland China, which were off following President Trump’s 10% tariff threat, which prompted profit-taking after six days of gains.
US President Donald Trump had threatened 60% tariffs on Chinese goods on his campaign trail.
Global shares rose on Friday buoyed by the prospect of lower U.S. interest rates and a U.S.-China trade deal following comments from President Donald Trump, while the yen was choppy after the Bank of Japan delivered a widely expected rate hike.
The Company makes available through the Investor Relations section of its internet website at http://ir.yumchina.com its filings with the HKEX as soon as reasonably practicable after electronically filing such materials with the HKEX. These filings may also be obtained by visiting the HKEX's website at http://www.hkex.com.hk.
U.S.-based Prolium Biosciences has now agreed to pay InnoCare and Keymed $17.5 million in upfront and near-term payments to develop and commercialize ICP-B02 as a cancer drug outside of China. Prolium also has the right to develop ICP-B02 in non-cancer indications globally, according to a filling with the Hong Kong Stock Exchange (PDF).
Asia-Pacific markets were set to open higher Monday, ahead of Donald Trump's inauguration with investors awaiting greater clarity on the policies of the incoming U.S. administration. Australia's S&P/ASX 200 rose 0.2% at the open.
To promote business collaboration and bilateral cooperation between the Hong Kong Special Administrative Region (HKSAR) and Indonesia, Mr Paul Chan, Financial Secretary of the HKSAR, visited Indonesia from January 8 – 10.
HONG KONG -- The historic legislation for Basic Law Article 23, aimed at safeguarding national security and ensuring Hong Kong's stability and development, has topped a list of the ten most significant policies by the Hong Kong Special Administrative Region (HKSAR) government in 2024.